Curative Biosciences Inc. Stock Analysis CBDX
Curative Biosciences, Inc. is engaged in the development and marketing of novel therapeutics. The company is headquartered in Miami, Florida. The company went IPO on 2004-08-26. The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The firm through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
Read More Curative Biosciences Inc (CBDX) Chart
Key Statistics of Curative Biosciences Inc (CBDX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
4815.00P/E Ratio (TTM)
-52 Week Range
Market Cap
25.79KAvg. Volume
57.41KDividend Yield
-Financial Metrics & Statements of Curative Biosciences Inc (CBDX)
FAQ's for Curative Biosciences Inc (CBDX)
- According to Musaffa’s Shariah screening methodology, Curative Biosciences Inc (CBDX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.